Christopher Kok

Kotra Pharma (M) Sdn Bhd

Kotra Pharma (M) Sdn. Bhd. (KPM) is a wholly-owned subsidiary of Kotra Industries Bhd. (KIB), a company listed on the Main Board of Bursa Malaysia. After 25 years of manufacturing excellence, KPM ranks today as one of South East Asia's leading producers of pharmaceutical products with best-selling brands i.e. over- the-counter (OTC) health supplements Appeton, nutriceutical beverage Booster, and a comprehensive range of prescriptive products under Axcel and Vaxcel. To date, KPM has 181 products registered with the National Pharmaceutical Control Board covering various dosage forms which include tablets, capsules, cream / ointment / gel, liquid, dry powder preparations and injectables. In 2002, when Malaysia was admitted as a member country for Pharmaceutical Inspection Convention Scheme, KPM was selected to be audited for the quality inspection on its facilities. One year later, in January 2003, KPM was awarded the prestigious ISO9001:2000 certification for its Quality Manufacture, Design and Development of pharmaceutical products. KPM's foreign market has expanded vigorously to more than 12 countries beyond ASEAN nations. The new millennium saw KPM venturing into a new company vision, that by year 2020, to have set a global standard for pharmaceutical companies worldwide and to have been able to lead the way in "Humanising Health". The company has matured into one of the leading generic drug manufacturers contributing to import substitution of branded medicines.